American Healthcare REIT (AHR) FY2020 results: revenue $1.1 billion, down 2.7% on the year
American Healthcare REIT, Inc. (AHR) reported revenue of $1.1 billion for fiscal 2020, the year ended 31 December 2020, down 2.7% on the year before. Net income was $2 million, and diluted earnings per share $0.05. The figures are the company's own, from the 10-K it filed with the SEC on 26 March 2021.
Revenue
$1.1 billion
-2.7% on the year
FY2016FY2020
Operating margin
20.4%
20.1% a year earlier
FY2016FY2020
Net income
$2 million
FY2016FY2020
Diluted EPS
$0.05
FY2016FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
1,069
1,099
84.5
-2.7%
Cost of revenue
994
19.2
11.5
+5,068.7%
Gross profit
75.3
n/a
73.0
Gross margin
7.0%
n/a
86.4%
Operating income
218
221
-1.7
-1.4%
Operating margin
20.4%
20.1%
-2.0%
Interest expense
71.3
78.6
6.8
-9.3%
Pre-tax income
5.8
0.7
-8.6
+760.9%
Income tax
-3.1
1.5
0.0
Effective tax rate
-53.2%
226.8%
n/a
Net income
2.2
-5.0
-8.4
Net margin
0.2%
-0.5%
-9.9%
Diluted EPS
$0.05
-$0.12
-$0.60
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
219
117
15.4
+86.6%
Capital expenditure
8.3
6.5
4.3
+27.9%
Free cash flow
211
111
11.2
+90.0%
Free cash flow margin
19.7%
10.1%
13.2%
Cash from investing
-148
-103
-412
Cash from financing
-8.8
2.7
404
Depreciation and amortisation
98.9
111
32.7
-11.3%
Share-based compensation
-1.3
2.7
0.2
Buybacks
23.1
89.9
3.3
-74.3%
Dividends paid
27.0
62.6
14.0
-56.9%
Dividend per share
$0.45
$2.40
$2.40
-81.2%
Diluted shares, weighted
45m
45m
n/a
-1.1%
Shares outstanding at period end
180m
n/a
n/a
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
866
590
n/a
+46.8%
Non-controlling interest
168
0.0
n/a
Debt
1,654
423
n/a
+291.2%
Other liabilities
546
55.4
n/a
+886.6%
Total liabilities and equity
3,235
1,068
n/a
+202.8%
Goodwill
75.3
n/a
n/a
Intangible assets
155
74.0
n/a
+109.0%
Securities held for sale or to maturity
75.9
n/a
n/a
Cash and equivalents
113
53.1
n/a
+113.0%
Inventory
24.7
n/a
n/a
Other assets
2,791
941
787
+196.6%
Total assets
3,235
1,068
n/a
+202.8%
10-K for the year ended 31 December 2020, filed 26 March 2021: the filing.